Matthew Clement
Impact in
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
-
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
-
- Chemotherapy-induced organ toxicity mitigation 1
- Lymphoma Diagnosis and Treatment 1
- Oncology 2
- Clusterin in disease pathology 1
- Co-authors
- David A. Price (2 shared papers)Linda Wooldridge (2 shared papers)Ruth Seggewiss (2 shared papers)Emma Gostick (2 shared papers)Andrew K. Sewell (2 shared papers)Vishal S. Vaidya (2 shared papers)Joseph V. Bonventre (2 shared papers)Craig T. Jordan (1 shared paper)
- Journals
- Toxicological Sciences (2 papers)Clinical Cancer Research (1 paper)Blood (1 paper)Journal of Immunological Methods (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Matthew Clement
5 papers receiving 472 citations
Peers
Comparison fields: 5 of 67
- Genetics 130
- Immunology 174
- Hematology 78
- Nephrology 38
- Oncology 91
Countries citing papers authored by Matthew Clement
This map shows the geographic impact of Matthew Clement's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Clement with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Clement more than expected).
Fields of papers citing papers by Matthew Clement
This network shows the impact of papers produced by Matthew Clement. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Clement. The network helps show where Matthew Clement may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Clement, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 132 | |
| 2 | 2008 | 117 | |
| 3 | 2009 | 113 | |
| 4 | 2008 | 108 | |
| 5 | 2010 | 7 |
About Matthew Clement
Matthew Clement is a scholar working on Pathology and Forensic Medicine, Oncology, Public Health, Environmental and Occupational Health, Hematology and Molecular Biology, having authored 5 papers that have together received 477 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Metabolomics and Mass Spectrometry Studies (1 paper), Chronic Kidney Disease and Diabetes (1 paper), Chemotherapy-induced organ toxicity mitigation (1 paper), Clusterin in disease pathology (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Genetics (130 citations), Immunology (174 citations), Hematology (78 citations), Nephrology (38 citations) and Oncology (91 citations). Matthew Clement has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include David A. Price, Linda Wooldridge, Ruth Seggewiss, Emma Gostick, Andrew K. Sewell, Vishal S. Vaidya, Joseph V. Bonventre, Craig T. Jordan, Melanie Adler and Chris Jenkins. Their work appears in journals such as Toxicological Sciences, Clinical Cancer Research, Blood and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.